AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback